BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28981976)

  • 1. Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.
    Angelino G; De Angelis P; Faraci S; Rea F; Romeo EF; Torroni F; Tambucci R; Claps A; Francalanci P; Chiriaco M; Di Matteo G; Cancrini C; Palma P; D'Argenio P; Dall'Oglio L; Rossi P; Finocchi A
    Pediatr Allergy Immunol; 2017 Dec; 28(8):801-809. PubMed ID: 28981976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal involvement in chronic granulomatous disease.
    Marciano BE; Rosenzweig SD; Kleiner DE; Anderson VL; Darnell DN; Anaya-O'Brien S; Hilligoss DM; Malech HL; Gallin JI; Holland SM
    Pediatrics; 2004 Aug; 114(2):462-8. PubMed ID: 15286231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
    Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs LM; Skoda-Smith S; Chandrakasan S; Yu LC; Oshrine BR; Cuvelier GDE; Thakar MS; Chen K; Teira P; Shenoy S; Phelan R; Forbes LR; Chellapandian D; Dávila Saldaña BJ; Shah AJ; Weinacht KG; Joshi A; Boulad F; Quigg TC; Dvorak CC; Grossman D; Torgerson T; Graham P; Prasad V; Knutsen A; Chong H; Miller H; de la Morena MT; DeSantes K; Cowan MJ; Notarangelo LD; Kohn DB; Stenger E; Pai SY; Routes JM; Puck JM; Kapoor N; Pulsipher MA; Malech HL; Parikh S; Kang EM;
    J Clin Immunol; 2019 Oct; 39(7):653-667. PubMed ID: 31376032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of screening for chronic granulomatous disease in patients with inflammatory bowel disease.
    Jaggi P; Scherzer R; Knieper R; Mousa H; Prasad V
    J Clin Immunol; 2012 Feb; 32(1):78-81. PubMed ID: 22089701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease.
    Magnani A; Brosselin P; Beauté J; de Vergnes N; Mouy R; Debré M; Suarez F; Hermine O; Lortholary O; Blanche S; Fischer A; Mahlaoui N
    J Allergy Clin Immunol; 2014 Sep; 134(3):655-662.e8. PubMed ID: 24985400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlap, common features, and essential differences in pediatric granulomatous inflammatory bowel disease.
    Damen GM; van Krieken JH; Hoppenreijs E; van Os E; Tolboom JJ; Warris A; Yntema JB; Nieuwenhuis EE; Escher JC
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):690-7. PubMed ID: 20683205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India.
    Rawat A; Vignesh P; Sharma A; Shandilya JK; Sharma M; Suri D; Gupta A; Gautam V; Ray P; Rudramurthy SM; Chakrabarti A; Imai K; Nonoyama S; Ohara O; Lau YL; Singh S
    J Clin Immunol; 2017 Apr; 37(3):319-328. PubMed ID: 28332028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry.
    LaBere B; Gutierrez MJ; Wright H; Garabedian E; Ochs HD; Fuleihan RL; Secord E; Marsh R; Sullivan KE; Cunningham-Rundles C; Notarangelo LD; Chen K
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1325-1333.e5. PubMed ID: 35033700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease in Thai children: presentations and outcomes of treatment.
    Treepongkaruna S; Pienvichit P; Sornmayura P; Pornkul R; Wisedopas N; Phuapradit P
    Asian Pac J Allergy Immunol; 2006 Mar; 24(1):73-9. PubMed ID: 16913191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy.
    Khangura SK; Kamal N; Ho N; Quezado M; Zhao X; Marciano B; Simpson J; Zerbe C; Uzel G; Yao MD; DeRavin SS; Hadigan C; Kuhns DB; Gallin JI; Malech HL; Holland SM; Heller T
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):395-402.e5. PubMed ID: 26545803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small bowel disease prevalence on video capsule endoscopy in chronic granulomatous disease-associated inflammatory bowel disease.
    Bhattacharya S; Wong U; Khalid M; Blaney H; Menkart MG; Oringher JL; Taneja SL; Zerbe CS; De Ravin SS; Malech HL; Holland SM; Koh C; Heller T
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2083-2089. PubMed ID: 37743535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leopard Skin-Like Colonic Mucosa: A Novel Endoscopic Finding of Chronic Granulomatous Disease-Associated Colitis.
    Obayashi N; Arai K; Nakano N; Mizukami T; Kawai T; Yamamoto S; Shimizu H; Nunoi H; Shimizu T; Tang J; Onodera M
    J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):56-9. PubMed ID: 26164846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France.
    Dunogué B; Pilmis B; Mahlaoui N; Elie C; Coignard-Biehler H; Amazzough K; Noël N; Salvator H; Catherinot E; Couderc LJ; Sokol H; Lanternier F; Fouyssac F; Bardet J; Bustamante J; Gougerot-Pocidalo MA; Barlogis V; Masseau A; Durieu I; Lecuit M; Suarez F; Fischer A; Blanche S; Hermine O; Lortholary O
    Clin Infect Dis; 2017 Mar; 64(6):767-775. PubMed ID: 28362954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study.
    Bramuzzo M; Arrigo S; Romano C; Filardi MC; Lionetti P; Agrusti A; Dipasquale V; Paci M; Zuin G; Aloi M; Strisciuglio C; Miele E; Pastore M; Martelossi S; Alvisi P;
    United European Gastroenterol J; 2019 Jul; 7(6):759-766. PubMed ID: 31316780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Huang C; De Ravin SS; Paul AR; Heller T; Ho N; Wu Datta L; Zerbe CS; Marciano BE; Kuhns DB; Kader HA; Holland SM; Malech HL; Brant SR;
    Inflamm Bowel Dis; 2016 Dec; 22(12):2794-2801. PubMed ID: 27861181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease.
    Marks DJ; Miyagi K; Rahman FZ; Novelli M; Bloom SL; Segal AW
    Am J Gastroenterol; 2009 Jan; 104(1):117-24. PubMed ID: 19098859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.
    Blumental S; Mouy R; Mahlaoui N; Bougnoux ME; Debré M; Beauté J; Lortholary O; Blanche S; Fischer A
    Clin Infect Dis; 2011 Dec; 53(12):e159-69. PubMed ID: 22080130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of colitis in chronic granulomatous disease.
    Schäppi MG; Klein NJ; Lindley KJ; Rampling D; Smith VV; Goldblatt D; Milla PJ
    J Pediatr Gastroenterol Nutr; 2003 May; 36(5):623-31. PubMed ID: 12717086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.